Inactive/Delisted stock

Sonendo Stock (NYSE:SONX)


Chart

Previous Close

$NaN

52W Range

$1.00 - $5.00

50D Avg

$2.46

200D Avg

$2.46

Market Cap

$1.17M

Avg Vol (3M)

$3.07K

Beta

1.48

Div Yield

-

SONX Company Profile


Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

200

IPO Date

Oct 29, 2021

Website

SONX Performance


Peer Comparison


TickerCompany
KIDSOrthoPediatrics Corp.
FNAParagon 28, Inc.
SGHTSight Sciences, Inc.
NPCENeuroPace, Inc.
SSKNSTRATA Skin Sciences, Inc.
AORTArtivion, Inc.
LIVNLivaNova PLC
SRDXSurmodics, Inc.
ANIKAnika Therapeutics, Inc.
OFIXOrthofix Medical Inc.
CVRXCVRx, Inc.